| Serial Number | 79302549 |
| Word Mark | BILIX |
| Filing Date | Wednesday, November 11, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 6, 2022 |
| Registration Number | 6835721 |
| Registration Date | Tuesday, September 6, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 21, 2022 |
| Goods and Services | Pharmaceutical preparations for neurological disease; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for ocular and intraocular surgery; pharmaceutical preparations for rare autoimmune diseases in the nature of autoimmune lymphoproliferative syndrome, lupus, and multiple sclerosis; pharmaceutical products for the treatment of rare autoimmune diseases and disorders; pharmaceutical products for the prevention and treatment of rare genetic diseases affecting red blood cells; medicated ointments for treating dermatological conditions; antibiotic ointments; mentholated ointment for medical use; anti-inflammatory ointments; chemical reagents for purposes of medical diagnosis; diagnostic preparations for diagnosing inflammatory diseases; diagnostic radiopharmaceutical preparations; pharmaceutical and biological preparations for use in diagnosis, namely, for use as ultrasound and x-ray contrast reagents; antibiotics; anti-inflammatory preparations; anti-cancer preparations; biological preparations for the treatment of cancer; cardiovascular pharmaceutical preparations; dermatological pharmaceutical products; diagnostic preparations for medical or veterinary purposes; genetic identity tests comprised of reagents for medical purposes; human vaccine preparations; medicines for dental purposes; medicines for intestinal disorders; ophthalmic preparations; pharmaceutical agents affecting digestive organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting sensory organs; pharmaceutical preparations acting on the central nervous system; pharmaceutical agents for epidermis; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating skin disorders; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; pharmaceutical products for treating respiratory diseases; pharmaceuticals for the treatment of erectile dysfunction; preparations for the treatment of asthma; tumor suppressing agents; vaccines; immunoassay reagents for medical use |
| Goods and Services | Pharmaceutical research services; drug discovery services; medical research; pharmaceutical product evaluation; scientific investigations for medical purposes; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; consulting on the testing, inspection and research of medical products for quality control purposes; providing information on the testing, inspection and research of medical products for quality control purposes; industrial research in the fields of medicine, health and pharmacology; engineering services in the medical technology field |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 22, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 22, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bilix Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Bilix Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Bilix Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Tuesday, January 3, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, December 9, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, December 9, 2022 | FINAL DISPOSITION PROCESSED |
| Tuesday, December 6, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, September 6, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 6, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Monday, July 11, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, July 5, 2022 | NOTIFICATION PROCESSED BY IB |
| Wednesday, June 22, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 22, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, June 21, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 21, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 8, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 8, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 1, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, May 13, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, April 28, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, April 28, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, April 28, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, April 28, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, March 31, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 31, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 31, 2022 | ASSIGNED TO LIE |
| Tuesday, March 29, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 29, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 29, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 29, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 29, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 29, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, October 29, 2021 | NON-FINAL ACTION WRITTEN |
| Thursday, September 30, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 30, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 30, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 17, 2021 | REFUSAL PROCESSED BY IB |
| Monday, April 26, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, April 26, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, April 23, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, April 22, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, April 21, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, January 26, 2021 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 22, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, January 21, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |